Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 4321-4330 Newer>

The Motley Fool November 5, 2004 Roger Nusbaum	The Tale of Teva Generic drug companies like Teva may offer a smart way to own health care. However, the company's good fortune hit a bump when rival Andrx got pummeled with a bad earnings announcement, and Teva traded down in sympathy.
The Motley Fool November 5, 2004 Phil Wohl	WebMD Needs a Shot The online provider of health-care information shares have declined more than 5% today to a price of $7.22 per share. The company appears to be putting a bandage on its problems instead of fully treating the issues.
The Motley Fool November 5, 2004 Mike Cianciolo	Retailers Rebound Most retailers post impressive sales figures for October.
The Motley Fool November 5, 2004 W.D. Crotty	Taser for Half the Price For the third time this year, the company is splitting its stock.
The Motley Fool November 5, 2004 Tim Beyers	A Revival at Hand? Nokia seeks a resurgence via new handsets. A resurgence in the stock price from a two-year low achieved earlier this year demonstrates that investors think a revival is at hand.
The Motley Fool November 5, 2004 John Bluis	How FAROble Must It Be? Another strong quarter for FARO and another shrug of the shoulders by Mr. Market. With increasing cash, no debt, good return on equity, and slowing dilution, a significant drop in price may simply mean it's time to add more shares.
The Motley Fool November 5, 2004 W.D. Crotty	Top Banana Gets Called Out With operating income down and requests for dividends, Chiquita's conference call was no fun.
The Motley Fool November 5, 2004 Wherrett & Yelovich	Lumera Tries to Shine Does this nanotechnology company have potential? At a current price of $8.05 giving a price to sales of more than 450, Lumera looks expensive. As a company looking to light up the stadium, it's struggling to light up even the closet right now.
The Motley Fool November 5, 2004 Nathan Slaughter	Jackpot at 30,000 Feet? Ryanair, Europe's largest low-cost airline, might introduce in-flight gaming. Despite a modest 3% decline in average revenues per passenger (or yields), the company topped expectations by posting a 15% rise in net income.
The Motley Fool November 5, 2004 Philip Durell	Beat the Street With Value Do you want better returns? Here's how to get them: be a value investor.
<Older 4321-4330 Newer> Return to current articles.